| Name | Title | Contact Details |
|---|---|---|
Katherine Cook |
Associate Director of Information Security | Profile |
Amit Jain |
Chief Technology Officer | Profile |
Michael Goncalves |
Director, Information Security | Profile |
Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.
endurance enterprises incorpor is a Bozeman, MT-based company in the Business Services sector.
Mg Mako is a Santa Fe Springs, CA-based company in the Business Services sector.
Drb Group LLC is a Mars, PA-based company in the Business Services sector.
The Dot Corporation is a Irvine, CA-based company in the Business Services sector.